Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$1.70B
↑ 1258% above average
Average (8y)
$125.46M
Historical baseline
Range
High:$1.70B
Low:$-206.69M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $1.70B | +924.1% |
| 2023 | $-206.69M | -64.3% |
| 2022 | $-125.82M | -66.9% |
| 2021 | $-75.37M | -18.1% |
| 2020 | $-63.80M | -49.7% |
| 2019 | $-42.60M | -48.1% |
| 2018 | $-28.77M | -49.0% |
| 2017 | $-19.30M | -62.3% |
| 2016 | $-11.89M | - |